220 related articles for article (PubMed ID: 22107053)
1. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin.
Rosales-Corral SA; Acuña-Castroviejo D; Coto-Montes A; Boga JA; Manchester LC; Fuentes-Broto L; Korkmaz A; Ma S; Tan DX; Reiter RJ
J Pineal Res; 2012 Mar; 52(2):167-202. PubMed ID: 22107053
[TBL] [Abstract][Full Text] [Related]
2. A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin.
van Rensburg SJ; Daniels WM; Potocnik FC; van Zyl JM; Taljaard JJ; Emsley RA
S Afr Med J; 1997 Sep; 87(9):1111-5. PubMed ID: 9358827
[TBL] [Abstract][Full Text] [Related]
3. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases.
Lahiri DK; Chen DM; Lahiri P; Bondy S; Greig NH
Ann N Y Acad Sci; 2005 Nov; 1056():430-49. PubMed ID: 16387707
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
5. Role of melatonin in Alzheimer-like neurodegeneration.
Wang JZ; Wang ZF
Acta Pharmacol Sin; 2006 Jan; 27(1):41-9. PubMed ID: 16364209
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of melatonin in experimental models of Alzheimer disease.
Cheng Y; Feng Z; Zhang QZ; Zhang JT
Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Melatonin in Alleviating Alzheimer's Disease.
Shukla M; Govitrapong P; Boontem P; Reiter RJ; Satayavivad J
Curr Neuropharmacol; 2017; 15(7):1010-1031. PubMed ID: 28294066
[TBL] [Abstract][Full Text] [Related]
8. Melatonin in Alzheimer's disease.
Lin L; Huang QX; Yang SS; Chu J; Wang JZ; Tian Q
Int J Mol Sci; 2013 Jul; 14(7):14575-93. PubMed ID: 23857055
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
[TBL] [Abstract][Full Text] [Related]
10. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
Blass JP; Gibson GE
Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease.
Gongadze N; Antelava N; Kezeli T; Okudjava M; Pachkoria K
Georgian Med News; 2008 Feb; (155):44-8. PubMed ID: 18401056
[TBL] [Abstract][Full Text] [Related]
12. Can chronic increased intracranial pressure or exposure to repetitive intermittent intracranial pressure elevations raise your risk for Alzheimer's disease?
Wostyn P
Med Hypotheses; 2004; 62(6):925-30. PubMed ID: 15142650
[TBL] [Abstract][Full Text] [Related]
13. Calcium dysregulation in Alzheimer's disease.
Bojarski L; Herms J; Kuznicki J
Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
[TBL] [Abstract][Full Text] [Related]
14. Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology?
Bencherif M; Lippiello PM
Med Hypotheses; 2010 Feb; 74(2):281-5. PubMed ID: 19800174
[TBL] [Abstract][Full Text] [Related]
15. The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease.
Jeynes B; Provias J
J Neurosci Res; 2011 Jan; 89(1):22-8. PubMed ID: 21046564
[TBL] [Abstract][Full Text] [Related]
16. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective role of melatonin against amyloid beta peptide injected mice.
Masilamoni JG; Jesudason EP; Dhandayuthapani S; Ashok BS; Vignesh S; Jebaraj WC; Paul SF; Jayakumar R
Free Radic Res; 2008 Jul; 42(7):661-73. PubMed ID: 18654881
[TBL] [Abstract][Full Text] [Related]
18. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
Feng Z; Qin C; Chang Y; Zhang JT
Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and Alzheimer's disease.
Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease.
Pappolla MA; Chyan YJ; Poeggeler B; Frangione B; Wilson G; Ghiso J; Reiter RJ
J Neural Transm (Vienna); 2000; 107(2):203-31. PubMed ID: 10847561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
